Proliferating cell nuclear antigen (PCNA) for both DNA replication and repair. Most prominent among its necessary functions is to stimulate the processivity and thereby the activity of DNA polymerase delta (pol delta). The objective of this research is to establish the role of PCNA in human mutagenesis is based upon detailed understanding of the mechanisms by which it stimulates pol delta. Since complex formation between human PCNA and pol delta is absolutely DNA-dependent, the hypothesis that complex formation differs with lesion-containing DNA will be tested. Similar tests will be performed for interactions of PCNA and pol delta with other proteins including p21, RF-C and FEN-1. Each represents a functionally (biologically) distinct class of PCNA-interacting macromolecule. Explicit insights will be obtained into the interactions of PCNA-interacting macromolecule. Explicit insights will be obtained functionally (biologically) distinct class of PCNA-interacting, macromolecule. Explicit insights will be obtained into the interactions of PCNA with normal versus damaged DNA, in the presence and absence of other proteins. In the presence of normal (unmutated) PCNA, pol delta is 1-2 orders of magnitude more error-prone (relative to pol delta alone). It was speculated that this, the putative """"""""mutator"""""""" effect of PCNA arises from the fundamental mechanism of pol delta-stimulation by PCNA and is hence, unavoidable. This leads to the hypothesis that a group of human mutations is actually secondary, and results from primary or underlying mutations in PCNA. Since these PCNA mutations would not be expected to interfere with either replication or repair, it was further speculated that they would be undiscovered. This proposal outlines plans to test the hypothesis that primary mutations in PCNA lead to secondary mutations of biomedical importance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
2P01ES004068-14
Application #
6301316
Study Section
Project Start
2000-04-10
Project End
2001-03-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2000
Total Cost
$218,986
Indirect Cost
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Yun, Byeong Hwa; Guo, Jingshu; Turesky, Robert J (2018) Formalin-Fixed Paraffin-Embedded Tissues-An Untapped Biospecimen for Biomonitoring DNA Adducts by Mass Spectrometry. Toxics 6:
Jelakovi?, Bojan; Vukovi? Lela, Ivana; Karanovi?, Sandra et al. (2015) Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants. Clin J Am Soc Nephrol 10:215-23
Romanov, Victor; Whyard, Terry C; Waltzer, Wayne C et al. (2015) Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch Toxicol 89:47-56
Yun, Byeong Hwa; Sidorenko, Viktoriya S; Rosenquist, Thomas A et al. (2015) New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid. Toxicol Res (Camb) 4:763-776
Castells, Xavier; Karanovi?, Sandra; Ardin, Maude et al. (2015) Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid. Cancer Epidemiol Biomarkers Prev 24:1873-81
Jelakovi?, Bojan; Nikoli?, Jovan; Radovanovi?, Zoran et al. (2014) Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy. Nephrol Dial Transplant 29:2020-7
Ivkovi?, Vanja; Karanovi?, Sandra; Fištrek Prli?, Margareta et al. (2014) Is herbal tea consumption a factor in endemic nephropathy? Eur J Epidemiol 29:221-4
Yun, Byeong Hwa; Yao, Lihua; Jelakovi?, Bojan et al. (2014) Formalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogen. Carcinogenesis 35:2055-61
Attaluri, Sivaprasad; Iden, Charles R; Bonala, Radha R et al. (2014) Total synthesis of the aristolochic acids, their major metabolites, and related compounds. Chem Res Toxicol 27:1236-42
Sidorenko, Viktoriya S; Attaluri, Sivaprasad; Zaitseva, Irina et al. (2014) Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 35:1814-22

Showing the most recent 10 out of 136 publications